Submission Details
| 510(k) Number | K242721 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 10, 2024 |
| Decision Date | October 04, 2024 |
| Days to Decision | 24 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K242721 is an FDA 510(k) clearance for the Upper Arm Electronic Blood Pressure Monitor (FC-BP103, FC-BP106, FC-BP113, FC-BP120, FC-BP121, FC-BP130, FC-BP131), a System, Measurement, Blood-pressure, Non-invasive (Class II — Special Controls, product code DXN), submitted by Shenzhen Finicare Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on October 4, 2024, 24 days after receiving the submission on September 10, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1130.
| 510(k) Number | K242721 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 10, 2024 |
| Decision Date | October 04, 2024 |
| Days to Decision | 24 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXN — System, Measurement, Blood-pressure, Non-invasive |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1130 |